Money Concepts Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Money Concepts Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-478	Closed	-$73.7K	–	1268
2022 Q4	$73.7K	Buy	478 +424	+785%	+$62.6K	﹤0.01%	1094
2022 Q3	$7K	Sell	54 -25	-32%	-$3.51K	﹤0.01%	1136
2022 Q2	$11K	Sell	79 -580	-88%	-$80K	﹤0.01%	1010
2022 Q1	$98K	Buy	659 +370	+128%	+$54.7K	0.01%	998
2021 Q4	$47K	Buy	+289	New	+$46.7K	﹤0.01%	599
2021 Q1	$87K	Buy	540 +4	+0.7%	+$685	0.01%	533
2020 Q4	$90K	Buy	+536	New	+$87K	0.01%	473

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Money Concepts Capital's FBT Position: Q1 2023 in Review

Money Concepts Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2023, closing a stake of 478 shares — an estimated $73.7K sold.

Money Concepts Capital first reported a position in FBT in Q4 2020 and held it in 7 quarters. The position peaked at $98K in Q1 2022. 245 funds tracked by Wall St. Rank hold FBT as of Q1 2023.

Money Concepts Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2023 after selling out during the quarter.
Money Concepts Capital sold 478 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2023, an estimated $73.7K.
Money Concepts Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and held it in 7 quarters.
Money Concepts Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $98K in Q1 2022.
245 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.